N. Hribernik, “Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy”, Radiol Oncol, vol. 59, no. 1, pp. 43–53, Feb. 2025.